TMPO and neoplasm: Interestingly, when comparing the TP5 group with the combination therapy using both TP5 and WSAA, it was found that their immunoregulatory activities in H22 tumor-bearing mice were even stronger, suggesting that WSAA had additional positive impacts on enhancing immune responses when combined with TP5 stimulation for mice bearing tumors.